Announced Fri, 31 Jul · 16:10 IST
Hindustan Bio Sciences Q1 FY27: Zero revenue, Rs 11.29 lakh loss
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.0%1-day move
₹7.20
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.0-6.9-2.9-6.0-8.3-4.6————
Up moveDown movePending
AI summary
HBL reported zero revenue from operations in Q1 FY27 ended June 30, 2026, down from Rs 1.31 lakh in Q1 FY26. Total expenses were Rs 10.29 lakh vs Rs 32.41 lakh YoY. The company posted a loss of Rs 11.29 lakh vs a profit of Rs 1.40 lakh YoY. EPS stood at minus Rs 0.11. Reserves are negative at minus Rs 122.42 lakh.
Likely market impact
Zero revenue with ongoing losses and negative reserves raises sustainability concerns. Limited trading activity may continue.